SESSION TITLE: Occupational and Environmental Lung Diseases SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/10/2018 01:00 PM - 02:00 PM PURPOSE: Agricultural workers experience high rates of chronic inflammatory lung disease from inhalation of organic dusts. Interleukin (IL)-6 is an important cytokine linked to chronic lung disease and organic dust extract (ODE) exposure. IL-6 can activate either an anti-inflammatory (classic) or pro-inflammatory (trans) IL-6 signaling pathway. Blocking the trans-IL-6 pathway with a soluble gp130Fc protein may decrease inflammation and offer a future targeted therapy for agricultural workers. METHODS: C57BL/6 mice were pretreated with intraperitoneal injection of recombinant gp130Fc (2μg) or a vehicle control followed by intranasal inhalation of swine confinement facility ODE or a saline control daily for 9 days. Bronchoalveolar lavage fluid (BALF), lung tissue homogenates, and serum were collected for inflammatory, cellular, and cytokine analysis. Lungs were processed for histopathology and independently scored for inflammatory changes. Serum soluble-IL-6 receptor levels and serum IL-6 levels were used to determine whether gp130Fc treated animals obtained adequate therapy. Data collected from a minimum of 3 independent experiments with total of 8-12 mice per treatment group. RESULTS: ODE-induced neutrophil influx was not reduced by gp130Fc pre-treatments (p=0.61), but inflammatory mediators were decreased. Pretreatment with gp130Fc significantly reduced ODE-induced BALF levels of CXCL1 by 83% (p=0.021), CXCL2 by 102% (p=0.003), IL-6 by 86% (p=0.004), and TNF-α by 125% (p=0.009). In lung tissue, there was a significant increase in IL-12 by 72% (p=0.020), a non-significant decrease in IL-17 by 35% (p=0.400), and a non-significant increase in IL-13 by 38% (p=0.124). There were also non-significant reductions in ODE-induced lung histopathological inflammatory scoring marked by less alveolar inflammation (p=0.083), bronchial inflammation (p=0.083), and lymphoid aggregate development (p=0.100) in animals pretreated with gp130Fc. There were no differences in any outcome between vehicle injection+saline inhalation and gp130Fc injection+saline inhalation treatment groups. CONCLUSIONS: Targeting the trans-IL-6 signaling pathway by intraperitoneal administration of recombinant gp130Fc in mice prior to organic dust extract exposures attenuates the airway inflammatory response. The inhibitory effect of gp130Fc was predominately evident by reductions in ODE-induced inflammatory cytokines/chemokines and to a lesser degree in ODE-associated lung histopathology. CLINICAL IMPLICATIONS: In 2015 an estimated 2.05 million documented US citizens worked in agriculture. Of those who work with swine, up to 93% report development of respiratory symptoms. Chronic inflammatory lung disease has been well established in this sub-population. Identifying a targeted therapy, such as recombinant gp130Fc, that can prevent lung inflammation in these individuals could potentially offer an important clinical benefit. DISCLOSURES: No relevant relationships by Joseph Carrington, source=Web Response No relevant relationships by Amy Nelson, source=Web Response No relevant relationships by Jill Poole, source=Web Response No relevant relationships by Debra Romberger, source=Web Response No relevant relationships by Benjamin Swanson, source=Web Response